ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Taditional Chinese Medicine (TCM) for COVID-19 Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27N7673
Home | Market Reports | Health| Pharmacy
Global Taditional Chinese Medicine TCM for COVID 19 Market Insights and Forecast to 2028
BUY CHAPTERS

Global Taditional Chinese Medicine (TCM) for COVID-19 Market Research Report 2025

Code: QYRE-Auto-27N7673
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Yiling Pharmaceutical
Tianjin Chase Sun Pharmaceutical
Sunflower
Guizhou Yibai Pharmaceutical
Beijing Juxiechang Pharmaceutical
Jiren Pharmaceutical Group
Qingfeng Pharmaceutical Group
Southwest Pharmaceutical
Jiuzhitang
China Beijing Tong Ren Tang Group Co., Ltd.
Jiangsu Jichuan Holding Group Co., Ltd.

Taditional Chinese Medicine (TCM) for COVID-19 Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Taditional Chinese Medicine (TCM) for COVID-19 Market

Taditional Chinese Medicine (TCM) for COVID-19 Market

The global market for Taditional Chinese Medicine (TCM) for COVID-19 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Taditional Chinese Medicine (TCM) for COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Taditional Chinese Medicine (TCM) for COVID-19.
The Taditional Chinese Medicine (TCM) for COVID-19 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Taditional Chinese Medicine (TCM) for COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Taditional Chinese Medicine (TCM) for COVID-19 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Taditional Chinese Medicine (TCM) for COVID-19 Market Report

Report Metric Details
Report Name Taditional Chinese Medicine (TCM) for COVID-19 Market
CAGR 5%
Segment by Type
  • Lianhua Qingwen Capsule
  • Jinhua Qinggan Granules
  • Xuebijing Injection
  • TCM Prescription
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Yiling Pharmaceutical, Tianjin Chase Sun Pharmaceutical, Sunflower, Guizhou Yibai Pharmaceutical, Beijing Juxiechang Pharmaceutical, Jiren Pharmaceutical Group, Qingfeng Pharmaceutical Group, Southwest Pharmaceutical, Jiuzhitang, China Beijing Tong Ren Tang Group Co., Ltd., Jiangsu Jichuan Holding Group Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Taditional Chinese Medicine (TCM) for COVID-19 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Taditional Chinese Medicine (TCM) for COVID-19 Market report?

Ans: The main players in the Taditional Chinese Medicine (TCM) for COVID-19 Market are Yiling Pharmaceutical, Tianjin Chase Sun Pharmaceutical, Sunflower, Guizhou Yibai Pharmaceutical, Beijing Juxiechang Pharmaceutical, Jiren Pharmaceutical Group, Qingfeng Pharmaceutical Group, Southwest Pharmaceutical, Jiuzhitang, China Beijing Tong Ren Tang Group Co., Ltd., Jiangsu Jichuan Holding Group Co., Ltd.

What are the Application segmentation covered in the Taditional Chinese Medicine (TCM) for COVID-19 Market report?

Ans: The Applications covered in the Taditional Chinese Medicine (TCM) for COVID-19 Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Taditional Chinese Medicine (TCM) for COVID-19 Market report?

Ans: The Types covered in the Taditional Chinese Medicine (TCM) for COVID-19 Market report are Lianhua Qingwen Capsule, Jinhua Qinggan Granules, Xuebijing Injection, TCM Prescription, Other

Recommended Reports

COVID-19 Treatment

Chinese Medicine

Infection Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Lianhua Qingwen Capsule
1.2.3 Jinhua Qinggan Granules
1.2.4 Xuebijing Injection
1.2.5 TCM Prescription
1.2.6 Other
1.3 Market by Application
1.3.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Perspective (2020-2031)
2.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Growth Trends by Region
2.2.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Taditional Chinese Medicine (TCM) for COVID-19 Historic Market Size by Region (2020-2025)
2.2.3 Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Region (2026-2031)
2.3 Taditional Chinese Medicine (TCM) for COVID-19 Market Dynamics
2.3.1 Taditional Chinese Medicine (TCM) for COVID-19 Industry Trends
2.3.2 Taditional Chinese Medicine (TCM) for COVID-19 Market Drivers
2.3.3 Taditional Chinese Medicine (TCM) for COVID-19 Market Challenges
2.3.4 Taditional Chinese Medicine (TCM) for COVID-19 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Revenue
3.1.1 Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Revenue (2020-2025)
3.1.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Players (2020-2025)
3.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Taditional Chinese Medicine (TCM) for COVID-19 Revenue
3.4 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Concentration Ratio
3.4.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Taditional Chinese Medicine (TCM) for COVID-19 Revenue in 2024
3.5 Global Key Players of Taditional Chinese Medicine (TCM) for COVID-19 Head office and Area Served
3.6 Global Key Players of Taditional Chinese Medicine (TCM) for COVID-19, Product and Application
3.7 Global Key Players of Taditional Chinese Medicine (TCM) for COVID-19, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Taditional Chinese Medicine (TCM) for COVID-19 Breakdown Data by Type
4.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Historic Market Size by Type (2020-2025)
4.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Type (2026-2031)
5 Taditional Chinese Medicine (TCM) for COVID-19 Breakdown Data by Application
5.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Historic Market Size by Application (2020-2025)
5.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2020-2031)
6.2 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025)
6.4 North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2020-2031)
7.2 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025)
7.4 Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2020-2031)
8.2 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2020-2025)
8.4 Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2020-2031)
9.2 Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025)
9.4 Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2020-2031)
10.2 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025)
10.4 Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Yiling Pharmaceutical
11.1.1 Yiling Pharmaceutical Company Details
11.1.2 Yiling Pharmaceutical Business Overview
11.1.3 Yiling Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.1.4 Yiling Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.1.5 Yiling Pharmaceutical Recent Development
11.2 Tianjin Chase Sun Pharmaceutical
11.2.1 Tianjin Chase Sun Pharmaceutical Company Details
11.2.2 Tianjin Chase Sun Pharmaceutical Business Overview
11.2.3 Tianjin Chase Sun Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.2.4 Tianjin Chase Sun Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.2.5 Tianjin Chase Sun Pharmaceutical Recent Development
11.3 Sunflower
11.3.1 Sunflower Company Details
11.3.2 Sunflower Business Overview
11.3.3 Sunflower Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.3.4 Sunflower Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.3.5 Sunflower Recent Development
11.4 Guizhou Yibai Pharmaceutical
11.4.1 Guizhou Yibai Pharmaceutical Company Details
11.4.2 Guizhou Yibai Pharmaceutical Business Overview
11.4.3 Guizhou Yibai Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.4.4 Guizhou Yibai Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.4.5 Guizhou Yibai Pharmaceutical Recent Development
11.5 Beijing Juxiechang Pharmaceutical
11.5.1 Beijing Juxiechang Pharmaceutical Company Details
11.5.2 Beijing Juxiechang Pharmaceutical Business Overview
11.5.3 Beijing Juxiechang Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.5.4 Beijing Juxiechang Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.5.5 Beijing Juxiechang Pharmaceutical Recent Development
11.6 Jiren Pharmaceutical Group
11.6.1 Jiren Pharmaceutical Group Company Details
11.6.2 Jiren Pharmaceutical Group Business Overview
11.6.3 Jiren Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.6.4 Jiren Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.6.5 Jiren Pharmaceutical Group Recent Development
11.7 Qingfeng Pharmaceutical Group
11.7.1 Qingfeng Pharmaceutical Group Company Details
11.7.2 Qingfeng Pharmaceutical Group Business Overview
11.7.3 Qingfeng Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.7.4 Qingfeng Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.7.5 Qingfeng Pharmaceutical Group Recent Development
11.8 Southwest Pharmaceutical
11.8.1 Southwest Pharmaceutical Company Details
11.8.2 Southwest Pharmaceutical Business Overview
11.8.3 Southwest Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.8.4 Southwest Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.8.5 Southwest Pharmaceutical Recent Development
11.9 Jiuzhitang
11.9.1 Jiuzhitang Company Details
11.9.2 Jiuzhitang Business Overview
11.9.3 Jiuzhitang Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.9.4 Jiuzhitang Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.9.5 Jiuzhitang Recent Development
11.10 China Beijing Tong Ren Tang Group Co., Ltd.
11.10.1 China Beijing Tong Ren Tang Group Co., Ltd. Company Details
11.10.2 China Beijing Tong Ren Tang Group Co., Ltd. Business Overview
11.10.3 China Beijing Tong Ren Tang Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.10.4 China Beijing Tong Ren Tang Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.10.5 China Beijing Tong Ren Tang Group Co., Ltd. Recent Development
11.11 Jiangsu Jichuan Holding Group Co., Ltd.
11.11.1 Jiangsu Jichuan Holding Group Co., Ltd. Company Details
11.11.2 Jiangsu Jichuan Holding Group Co., Ltd. Business Overview
11.11.3 Jiangsu Jichuan Holding Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Introduction
11.11.4 Jiangsu Jichuan Holding Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
11.11.5 Jiangsu Jichuan Holding Group Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Yiling Pharmaceutical
Tianjin Chase Sun Pharmaceutical
Sunflower
Guizhou Yibai Pharmaceutical
Beijing Juxiechang Pharmaceutical
Jiren Pharmaceutical Group
Qingfeng Pharmaceutical Group
Southwest Pharmaceutical
Jiuzhitang
China Beijing Tong Ren Tang Group Co., Ltd.
Jiangsu Jichuan Holding Group Co., Ltd.
List of Tables
 Table 1. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Lianhua Qingwen Capsule
 Table 3. Key Players of Jinhua Qinggan Granules
 Table 4. Key Players of Xuebijing Injection
 Table 5. Key Players of TCM Prescription
 Table 6. Key Players of Other
 Table 7. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region (2020-2025)
 Table 11. Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region (2026-2031)
 Table 13. Taditional Chinese Medicine (TCM) for COVID-19 Market Trends
 Table 14. Taditional Chinese Medicine (TCM) for COVID-19 Market Drivers
 Table 15. Taditional Chinese Medicine (TCM) for COVID-19 Market Challenges
 Table 16. Taditional Chinese Medicine (TCM) for COVID-19 Market Restraints
 Table 17. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Players (2020-2025)
 Table 19. Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taditional Chinese Medicine (TCM) for COVID-19 as of 2024)
 Table 20. Ranking of Global Top Taditional Chinese Medicine (TCM) for COVID-19 Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Taditional Chinese Medicine (TCM) for COVID-19 Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Taditional Chinese Medicine (TCM) for COVID-19, Headquarters and Area Served
 Table 23. Global Key Players of Taditional Chinese Medicine (TCM) for COVID-19, Product and Application
 Table 24. Global Key Players of Taditional Chinese Medicine (TCM) for COVID-19, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Type (2020-2025)
 Table 28. Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Type (2026-2031)
 Table 30. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Application (2020-2025)
 Table 32. Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Application (2026-2031)
 Table 34. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Yiling Pharmaceutical Company Details
 Table 50. Yiling Pharmaceutical Business Overview
 Table 51. Yiling Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 52. Yiling Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 53. Yiling Pharmaceutical Recent Development
 Table 54. Tianjin Chase Sun Pharmaceutical Company Details
 Table 55. Tianjin Chase Sun Pharmaceutical Business Overview
 Table 56. Tianjin Chase Sun Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 57. Tianjin Chase Sun Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 58. Tianjin Chase Sun Pharmaceutical Recent Development
 Table 59. Sunflower Company Details
 Table 60. Sunflower Business Overview
 Table 61. Sunflower Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 62. Sunflower Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 63. Sunflower Recent Development
 Table 64. Guizhou Yibai Pharmaceutical Company Details
 Table 65. Guizhou Yibai Pharmaceutical Business Overview
 Table 66. Guizhou Yibai Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 67. Guizhou Yibai Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 68. Guizhou Yibai Pharmaceutical Recent Development
 Table 69. Beijing Juxiechang Pharmaceutical Company Details
 Table 70. Beijing Juxiechang Pharmaceutical Business Overview
 Table 71. Beijing Juxiechang Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 72. Beijing Juxiechang Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 73. Beijing Juxiechang Pharmaceutical Recent Development
 Table 74. Jiren Pharmaceutical Group Company Details
 Table 75. Jiren Pharmaceutical Group Business Overview
 Table 76. Jiren Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 77. Jiren Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 78. Jiren Pharmaceutical Group Recent Development
 Table 79. Qingfeng Pharmaceutical Group Company Details
 Table 80. Qingfeng Pharmaceutical Group Business Overview
 Table 81. Qingfeng Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 82. Qingfeng Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 83. Qingfeng Pharmaceutical Group Recent Development
 Table 84. Southwest Pharmaceutical Company Details
 Table 85. Southwest Pharmaceutical Business Overview
 Table 86. Southwest Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 87. Southwest Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 88. Southwest Pharmaceutical Recent Development
 Table 89. Jiuzhitang Company Details
 Table 90. Jiuzhitang Business Overview
 Table 91. Jiuzhitang Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 92. Jiuzhitang Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 93. Jiuzhitang Recent Development
 Table 94. China Beijing Tong Ren Tang Group Co., Ltd. Company Details
 Table 95. China Beijing Tong Ren Tang Group Co., Ltd. Business Overview
 Table 96. China Beijing Tong Ren Tang Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 97. China Beijing Tong Ren Tang Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 98. China Beijing Tong Ren Tang Group Co., Ltd. Recent Development
 Table 99. Jiangsu Jichuan Holding Group Co., Ltd. Company Details
 Table 100. Jiangsu Jichuan Holding Group Co., Ltd. Business Overview
 Table 101. Jiangsu Jichuan Holding Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Product
 Table 102. Jiangsu Jichuan Holding Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025) & (US$ Million)
 Table 103. Jiangsu Jichuan Holding Group Co., Ltd. Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Taditional Chinese Medicine (TCM) for COVID-19 Picture
 Figure 2. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Type: 2024 VS 2031
 Figure 4. Lianhua Qingwen Capsule Features
 Figure 5. Jinhua Qinggan Granules Features
 Figure 6. Xuebijing Injection Features
 Figure 7. TCM Prescription Features
 Figure 8. Other Features
 Figure 9. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Clinic Case Studies
 Figure 13. Other Case Studies
 Figure 14. Taditional Chinese Medicine (TCM) for COVID-19 Report Years Considered
 Figure 15. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region: 2024 VS 2031
 Figure 18. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Players in 2024
 Figure 19. Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taditional Chinese Medicine (TCM) for COVID-19 as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Taditional Chinese Medicine (TCM) for COVID-19 Revenue in 2024
 Figure 21. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2020-2031)
 Figure 23. United States Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2020-2031)
 Figure 27. Germany Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Region (2020-2031)
 Figure 35. China Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2020-2031)
 Figure 43. Mexico Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Country (2020-2031)
 Figure 47. Turkey Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Yiling Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 51. Tianjin Chase Sun Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 52. Sunflower Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 53. Guizhou Yibai Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 54. Beijing Juxiechang Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 55. Jiren Pharmaceutical Group Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 56. Qingfeng Pharmaceutical Group Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 57. Southwest Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 58. Jiuzhitang Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 59. China Beijing Tong Ren Tang Group Co., Ltd. Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 60. Jiangsu Jichuan Holding Group Co., Ltd. Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Traditional Chinese Medicine TCM Health Products Market Research Report 2025
Global Chinese Medicine Market Research Report 2024
Chinese Patent Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global COVID 19 Medicine Market Research Report 2024
Global TCM Granules in Prescriptions Market Research Report 2025
Chinese Medicine Pot Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Traditional Chinese Herbal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chinese Medicine Decoction Pot Market Research Report 2024
Global Chinese Herbal Therapy Market Research Report 2025
Specific Antiviral Drugs for COVID 19 Market
COVID 19 Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chinese Materia Medica for COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Traditional Chinese Medicine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Drug API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dengzhanhua Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Diagnostic Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions